Previous Close | 39.09 |
Open | 39.39 |
Bid | 37.20 x 1100 |
Ask | 37.22 x 900 |
Day's Range | 38.86 - 39.90 |
52 Week Range | 20.83 - 39.90 |
Volume | |
Avg. Volume | 445,693 |
Market Cap | 1.258B |
Beta (5Y Monthly) | 1.01 |
PE Ratio (TTM) | 30.50 |
EPS (TTM) | 1.29 |
Earnings Date | May 02, 2024 - May 06, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 40.00 |
Subscribe to Yahoo Finance Plus to view Fair Value for COLL
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
AppLovin, Kaiser Aluminum, Collegium Pharmaceutical, EMCOR Group and Textron have been highlighted in this Screen of The Week article.
Aquestive Therapeutics (AQST) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.